Log in to save to my catalogue

Targeting of CD163 + Macrophages in Inflammatory and Malignant Diseases

Targeting of CD163 + Macrophages in Inflammatory and Malignant Diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7432735

Targeting of CD163 + Macrophages in Inflammatory and Malignant Diseases

About this item

Full title

Targeting of CD163 + Macrophages in Inflammatory and Malignant Diseases

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2020-07, Vol.21 (15), p.5497

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The macrophage is a key cell in the pro- and anti-inflammatory response including that of the inflammatory microenvironment of malignant tumors. Much current drug development in chronic inflammatory diseases and cancer therefore focuses on the macrophage as a target for immunotherapy. However, this strategy is complicated by the pleiotropic phenoty...

Alternative Titles

Full title

Targeting of CD163 + Macrophages in Inflammatory and Malignant Diseases

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7432735

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7432735

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms21155497

How to access this item